NephroNet is an organization dedicated to providing resources to patients, practicing clinicians, and all individuals that are concerned with improving the care of patients with kidney disease. For patients, our goal is to be an educational resource that provides practical information to patients and their families. We endorse and are motivated as an organization to improve minority participation in CKD clinical research. We believe that by improving patient education of their disease, they will be better equipped to work with their physicians.
The NephroNet membership is composed of both academic and private physicians that work closely with the National Institutes of Health (NIH), American Society Nephrology, as well as large and small healthcare companies that are motivated to treat chronic kidney disease. The NephroNet membership has experts in all areas of kidney disease and is available for consultation that will ultimately bring new therapies to the renal community.
2019 2nd Annual NephroNet Nephrology Update
NephroNet is pleased to announce the second annual NephroNet Nephrology Update Meeting, which will be held at the Four Seasons Hotel September 13-15, 2019 in Midtown Atlanta, Georgia.
Some of this year’s topics will include: MGRS, Amyloid, Monoclonal Deposition Disease and Fibrillary GN- The New Data, lecture by Gerry Appel, MD, The role of B cell therapy in Lupus Nephritis by Brad Rovin MD. Randy Hennigar, MD will be doing a Path Case presentation and Richard Lafayette, MD will be giving us an update on FSGS: “The Nephrologist Nemesis”- Pathogenesis-Role of Melanocortin Receptor Pathways and Evolving Therapies.
Our objective is to facilitate collaboration between practicing physicians, clinical trial professionals and industry. We expect upwards of 100 MDs and NPs in attendance, and therefore have designed the session to be highly interactive, including extended Q/A sessions to maximize learnings. In addition, NephroNet will provide 10 accredited CME hours.
What Physician Attendees Said
“Best conference I’ve attended in the past 2 years.”
“Excellent Conference! Time allowed for plenty of discussions.”
“Should be held every year.”
“Spectacular conference. I’m going to tell my colleagues to attend in 2019.”
Understanding your options is the biggest hurdle. Learning more about your kidney condition is the first step.
Looking for help from a leading expert? Or want assistance writing your trial protocol? NephroNet is dedicated to provide resources to serve you and your patients.
Our team of experts provides you with the required scientific, therapeutic, and regulatory expertise to design studies for new drugs for the treatment of chronic kidney disease.